Inhibition of neuronal nitric oxide synthase (n-cNOS) reverses the corticotrophin-induced behavioral effects in rats

Molecular and Cellular Biochemistry

Volumn 183, Issue 1-2, 1998, Pages 25-38

  Reddy, Doodipala Samba ^a   Kulkarni, S K ^a  

^a PANJAB UNIVERSITY   (India)

Author keywords

Anxiety; Behavior; Corticotrophin; L arginine; L NMMA; Metyrapone; Neurosteroids; Nitric oxide; Nitric oxide synthase inhibitors

Indexed keywords

ARGININE; ASCORBIC ACID; CORTICOSTERONE; CORTICOTROPIN; DEXAMETHASONE; METYRAPONE; N(G) METHYLARGININE; NITRIC OXIDE SYNTHASE; NITRIC OXIDE SYNTHASE INHIBITOR; STEROID 11BETA MONOOXYGENASE;

ADRENAL GLAND; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BEHAVIOR; CONTROLLED STUDY; CORTICOSTERONE BLOOD LEVEL; ENZYME INHIBITION; MALE; MAZE TEST; NEUROENDOCRINE SYSTEM; NONHUMAN; RAT; STEROIDOGENESIS; TRANQUILIZING ACTIVITY;

ADRENOCORTICOTROPIC HORMONE; ANIMALS; BEHAVIOR, ANIMAL; BLOOD PRESSURE; DEXAMETHASONE; DOSE-RESPONSE RELATIONSHIP, DRUG; INJECTIONS, INTRAPERITONEAL; INJECTIONS, INTRAVENTRICULAR; INJECTIONS, SUBCUTANEOUS; MALE; MAZE LEARNING; MOTOR ACTIVITY; NERVE TISSUE PROTEINS; NITRIC OXIDE SYNTHASE; NITRIC OXIDE SYNTHASE TYPE I; RATS; RATS, WISTAR;

ANIMALIA;

EID: 0031776826     PISSN: 03008177     EISSN: None     Source Type: Journal    
DOI: 10.1023/A:1006815125689     Document Type: Article

References (35)

1. Moncada S, Palmer RMJ, Higgs EA: Nitric oxide: Physiology, pathophysiology, and pharmacology. Pharmacol Rev 43: 109-142, 1991
2. Palmer RMJ, Ferrige AG, Moncada S : Nitric oxide release accounts for biological activity of endothelium-derived relaxing factor. Nature 327: 524-526, 1987
3. Reddy DS, Singh M, Chopra K: Signalling mechanisms of cardiac hypertrophy. Ind J Pharmaco 128: 58-71, 1996
4. Rees DD, Palmer RMJ, Schulz R, Hodson HF, Moncada S: Characterization of three inhibitors of endothelial nitric oxide synthase in vitro and in vivo. Br J Pharmacol 101: 746-752, 1990
5. Brignola G, Calignano A, Rosa MD: Modulation of morphine antinociception in the mouse by endogenous nitric oxide. Br J Pharmacol 133: 1372-1376, 1994
6. Garthwiate J: Glutamate, nitric oxide and cell signalling in the nervous system. Trends Neurosci 14: 60-67, 1991
7. Bredt DS, Hwang, PM, Snyder SH: Localization of nitric oxide synthase indicating a neural role for nitric oxide. Nature 347: 768-770, 1990
8. Meller ST, Dykstra C, Gebhart GF: Production of endogenous nitric oxide and activation of soluble guanylate cyclase are required for N-methyl-D-aspartate-produced facilitation of the nociceptive tail-flick reflex. Fur J Pharmacol 214: 93-96, 1992
9. Bredt DS, Snyder SH: Isolation of nitric oxide synthetase, a calmodulin-requiring enzyme. Proc Natl Acad Sci USA 87: 682-685, 1990
10. Garthwaite J, Garthwaite G, Palmer RMJ, Moncada S: NMDA receptor activation induces nitric oxide synthesis from arginine from rat brain slices. Fur J Pharmacol 172: 413-116, 1989
11. Miki N, Kawabe Y, Kuriyama K: Activation of cerebral guanylate cyclase by nitric oxide. Biochem Biophys Res Commun 75: 815-856, 1991
12. Lonart G, Wang J, Johnson KM: Nitric oxide induces neurotransmitter release from hippocampal slices. Eur J Pharmacol 220: 271-272, 1992
13. 3H-dopamine from striatal slices. NeuroReport 3: 409-412, 1992
14. Dawson VL, Dawson, TM, London ED, Bredt DS, Snyder SH: Nitric oxide mediates glutamate neurotoxicity in primary cortical cultures. Proc Natl Acad Sci USA 88: 6368-6371, 1991
15. Schuman EM, Madison DV: A requirement for the intercellular messenger nitric oxide in long-term potentiation. Science 254: 1503-1506, 1991.
16. Sandi C, Guaza C: Evidence for nitric oxide-mediated rapid locomotor effects of corticosterone in a novel environment. Ann NY Acad Sci 756: 398-399, 1994
17. Sandi C, Venero C, Guaza C: Nitric oxide synthesis inhibitors prevent rapid behavioral effects of corticosterone in rats. Neuroendocrinology 63: 446-453, 1996
18. DeWied D, Jolies J: Neuropeptides derived from the pro-opiocortin: Behavioral, physiological and neurochemical effects. Physiol Rev 62: 976-1059, 1982
19. Pranzatelli MR: On the molecular mechanism of adrenocorticotrophic hormone in the CNS: Neurotransmitters and receptors. Exp Neurol 125: 142-161, 1994
20. Baram TZ, Schultz L: ACTH does not control neonatal seizures induced by administration of exogenous corticotropin-releasing hormone. Epilepsia 36: 174-178, 1995
21. Snead OC, Benton JW, Hosey LC, et al.: Treatment of infantile spasms with high-dose ACTH: Efficacy and plasma levels of ACTH and prednisone. Neurology 39: 1027-1031, 1989
22. Hoi T, Spruijt BM: The MSH/ACTH (4-9) analog ORG 2766 counteracts isolation-induced changes in social behavior via the amygdala. Peptides 13: 541-544, 1991
23. Niesink RJM, Van Ree JM: Normalizing effects of an ACTH 4-9 analog (ORG 2766) on 'disturbed' social behavior of rats: Implication of endogenous opioid systems. Science 221: 960-962, 1983
24. Kulkarni SK, Reddy DS: Neurosteroids: A new class of neuromodulators. Drugs Today 31: 433-455, 1995
25. Reddy DS, Kulkarni SK: Role of GABA-A and mitochondrial diazepam binding inhibitor receptors in the antistress activity of neurosteroids in mice. Psychopharmacology 128: 280-292, 1996
26. Reddy DS, Kulkarni SK: Differential anxiolytic effects of neurosteroids in the mirrored chamber behavior test in mice. Brain Res 752: 61-71, 1997
27. Reddy DS, Kulkarni SK: Neurosteroid co-administration prevents development of tolerance and augments recovery from chronic benzodiazepine withdrawal anxiety and hyperactivity in mice. Meth Find Exp Clin Pharmacol 19: 395-405, 1997
28. Kulkarni SK, Reddy DS: Animal behavioral models for testing antianxiety agents. Meth Find Exp Clin Pharmacol 18: 219-230, 1996
29. Griebel G, Sanger DJ, Perrault G: The use of the rat elevated plus-maze to discriminate between non-selective and BZ-1 (ω1) selective, benzodiazepine receptor ligands. Psychopharmacology 124: 245-254, 1996
30. Reddy DS, Singh M, Ghosh S, Ganguly NK: Role of cardiac reninangiotensin system in the development of pressure-overload left ventricular hypertrophy in rats with abdominal aortic constriction. Mol Cell Biochem 155: 1-11, 1996
31. James VHT, Mattingly D, Daly JR: Recommended method for the determination of plasma corticosteroids. Brit Med J 197: 310-313, 1971
32. DeWied D, Ferrari W (eds). Central actions of ACTH and related peptides. Padova: Fidia Research Series, 1986
33. Jain MR, Patil PP, Subhedar N: Intracranial metyrapone stimulates CRF-ACTH axis in the teleost, Clarias batrachus: Possible role of neurosteroids. NeuroReport 5: 2093-2096, 1994
34. Jain MR, Patil PP, Subhedar N: Direct action of metyrapone on brain: Implication in feeding. NeuroReport 5: 69-71, 1993
35. Weber DM, Eke BC, Maines MD: Corticosterone regulates heme oxygenase-2 and NO synthase transcription and protein expression in rat brain. J Neurochem 63: 953-62, 1994